Junshi Biosciences

Public 1877.HK · China

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
Approved
Next date
JS207, Phase 2 trial completes
Drugs
7
in active trials
Trials
13 active
14 since 2021

Drugs7

DrugHow it worksPartnerStageNext dateDetails
—
Approved 31 Dec 2027Phase 2 trial completes
PD-1/VEGF bispecific antibody
Phase 3 27 Nov 2026soonPhase 2 trial completes
—
Phase 3 31 Dec 2027Phase 2 trial completes
—
Phase 2 27 Nov 2026soonPhase 2 trial completes
—
Phase 2 30 Nov 2027Phase 2 trial completes
—
Phase 2 30 Nov 2027Phase 2 trial completes
—
Phase 1 15 Dec 2026soonPhase 1 trial completes

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow Junshi Biosciences

Following is part of Solo: you see every change to Junshi Biosciences the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in